Form 4: Amarin Director Odysseas Kostas D Reports Share Transactions

Sentiment:

SEC Form 4 Filing


Director Odysseas Kostas D reports acquisition and disposal of Amarin Corporation shares related to vesting of restricted stock units.

Summary

  • On April 18, 2025, Amarin Corporation director Odysseas Kostas D reported transactions involving American Depositary Shares (ADS).
  • These transactions include the acquisition of 838 ADS related to the vesting of restricted stock units (RSUs).
  • The director also disposed of 437 ADS to cover tax liabilities associated with the vesting of these securities at a price of $9.11 per share.
  • Following these transactions, the director directly owns 401 ADS and 1,676 RSUs.
  • The ADS ratio changed on April 11, 2025, where one ADS represents twenty ordinary shares.
  • The director was granted an award on April 18, 2024, that vests in three equal installments on April 18 of 2025, 2026, and 2027.

Sentiment

Score: 6

Explanation: The sentiment is neutral. The filing reflects routine transactions related to equity compensation. There is no indication of unusual activity or concerns.

Positives

  • The vesting of RSUs indicates that the director is meeting the conditions of the award, which could be tied to performance or tenure.

Negatives

  • The disposal of shares to cover tax liabilities, while common, slightly reduces the director's holdings.

Risks

  • The document does not explicitly state any risks.
  • However, insider transactions are always scrutinized, and any unusual patterns could raise concerns.

Industry Context

Form 4 filings are a routine part of regulatory compliance for publicly traded companies, providing transparency into insider transactions. These filings are closely watched by investors seeking insights into management's perspective on the company's prospects.

Comparison to Industry Standards

  • Comparing Amarin to similar pharmaceutical companies like Esperion or Madrigal Pharmaceuticals, insider transactions are a common occurrence.
  • The size and frequency of these transactions are generally in line with industry norms for directors receiving equity-based compensation.

Stakeholder Impact

  • The transactions have a minimal direct impact on stakeholders.
  • However, transparency in insider transactions is important for maintaining investor confidence.

Key Dates

DateDescription
04/18/2024Reporting Person was granted an award that vests in three equal installments on each of April 18, 2025, April 18, 2026 and April 18, 2027
04/11/2025The Issuer implemented a ratio change that one (1) American Depositary Share ('ADS') currently represents twenty (20) Ordinary Shares ('ADS Ratio Change')
04/18/2025Director acquired 838 ADS upon vesting of restricted stock units and disposed of 437 ADS for tax obligations.
04/22/2025Date of signature for the Form 4 filing.

Keywords

Amarin, Director, Odysseas Kostas D, ADS, RSU, Share Transactions, Form 4, Insider Trading

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.